1. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na + /K + -ATPase α1 subunit
   Yu-Long Lan et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Chemopreventive effects of some popular phytochemicals on human colon cancer: a review
   Yueliang Zhao et al, 2018, Food Funct. CrossRef
3. Bufalin induces protective autophagy by Cbl-b regulating mTOR and ERK signaling pathways in gastric cancer cells
   Hai-Yan Qi et al, 2019, Cell Biol Int CrossRef
4. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom
   Jun-Shan Liu et al, 2019, Fitoterapia CrossRef
5. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
   Chien-shan Cheng et al, 2019, Cancer Cell Int CrossRef
6. Evaluation of antimutagenic and cytotoxic activity of skin secretion extract of Rhinella marina and Rhaebo guttatus (Anura, Bufonidae)
   Angellica Fernandes de OLIVEIRA et al, 2019, Acta Amaz. CrossRef
7. Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients
   Rosa Jahangiri et al, 2019, Pathol. Oncol. Res. CrossRef
8. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
   Yueping Zhan et al, 2020, Cancer Sci CrossRef
9. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells
   Nam-Yi Kim et al, 2020 CrossRef
10. α-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK/mTOR signaling pathway activation
    Jian Sun et al, 2019, Int J Oncol CrossRef
11. Bufalin induces DNA damage response under hypoxic condition in myeloma cells
    Eri Fujii et al, 2018, Oncol Lett CrossRef
12. Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines.
    Ga-Young Lee et al, 2020, Chin J Integr Med CrossRef
13. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
    Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
14. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms.
    Fang-Jie Li et al, 2021, Arch Pharm (Weinheim) CrossRef
15. Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer
    Jinbao Chen et al, 2021, Cancer Letters CrossRef
16. Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
    Kai Fang et al, 2021, J Transl Med CrossRef
17. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer
    Heshi Liu et al, 2022, Acta Biomaterialia CrossRef
18. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer
    Mostafa Vaghari-Tabari et al, 2022, Cell Mol Biol Lett CrossRef
19. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
20. Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial–Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis
    Ling Ding et al, 2022, IJMS CrossRef
21. Evaluation of the Growth Suppressing and Stemness Inhibiting Effect of Cisplatin and 5 Fluorouracil on Human Epithelial Squamous Cell Carcinoma (HEp-2)
    Ahmed Kolade Oloyo et al, 2022, EJMED CrossRef
22. The synergistic function of long and short forms of β4GalT1 in p53-mediated drug resistance in bladder cancer cells
    Hongjiao Li et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
23. Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway
    Haijing Wang et al, 2023, Apoptosis CrossRef
24. Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
    Die Zhang et al, 2023, Heliyon CrossRef
25. Bufalin serves as a pharmaceutic that mitigates drug resistance
    Linxuan Miao et al, 2023, Drug Metabolism Reviews CrossRef
26. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
    Mehrdad Hashemi et al, 2023, Environmental Research CrossRef
27. Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells
    Donghao Tang et al, 2024, Apoptosis CrossRef